Estimating prevalence of osteoporosis: examples from industrialized countries

被引:289
|
作者
Wade, S. W. [1 ]
Strader, C. [2 ]
Fitzpatrick, L. A. [3 ]
Anthony, M. S. [4 ]
O'Malley, C. D. [4 ]
机构
[1] Wade Outcomes Res & Consulting, 358 South 700 East,Suite B-432, Salt Lake City, UT 84102 USA
[2] Kantar Hlth, 11960 Westline Ind Dr,Suite 180, St Louis, MO 63146 USA
[3] GlaxoSmithKline, 2301 Renaissance Blvd, King Of Prussia, PA 19406 USA
[4] Amgen Inc, One Amgen Ctr Dr,MS 24-2-A, Thousand Oaks, CA 91320 USA
关键词
Osteoporosis; Prevalence; Bonemineral density; Males; Females; NHANES;
D O I
10.1007/s11657-014-0182-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A In nine industrialized countries in North America, Europe, Japan, and Australia, country-specific osteoporosis prevalence (estimated from published data) at the total hip or hip/spine ranged from 9 to 38 % for women and 1 to 8 % for men. In these countries, osteoporosis affects up to 49 million individuals. Purpose Standardized country-specific prevalence estimates are scarce, limiting our ability to anticipate the potential global impact of osteoporosis. This study estimated the prevalence of osteoporosis in several industrialized countries (USA, Canada, five European countries, Australia, and Japan) using the World Health Organization (WHO) bone mineral density (BMD)-based definition of osteoporosis: BMD T-score assessed by dual-energy x-ray absorptiometry <=-2.5. Methods Osteoporosis prevalence was estimated for males and females aged 50 years and above using total hip BMD and then either total hip or spine BMD. We compiled published location-specific data, using the National Health and Nutrition Examination Survey (NHANES) III age and BMD reference groups, and adjusted for differences in disease definitions across sources. Relevant NHANES III ratios (e.g., male to female osteoporosis at the total hip) were applied where data were missing for countries outside the USA. Data were extrapolated from geographically similar countries as needed. Population counts for 2010 were used to estimate the number of individuals with osteoporosis in each country. Results For females, osteoporosis prevalence ranged from 9 % (UK) to 15 % (France and Germany) based on total hip BMD and from 16 % (USA) to 38 % (Japan) when spine BMD data were included. For males, prevalence ranged from 1 % (UK) to 4 % (Japan) based on total hip BMD and from 3 % (Canada) to 8 % (France, Germany, Italy, and Spain) when spine BMD data were included. Conclusions Up to 49 million individuals met the WHO osteoporosis criteria in a number of industrialized countries in North America, Europe, Japan, and Australia.
引用
收藏
页数:10
相关论文
共 50 条